---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-043517"
form_type: "8-K"
ticker: "ACOG"
cik: "0001655923"
company_name: "Alpha Cognition Inc."
filed_at: "2026-04-14T23:59:59+00:00"
generated_at: "2026-05-15T06:23:37.843240+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Alpha Cognition settles Galantos royalty obligations for EUR 5.2M one-time payment, ~40% discount

## Summary
- Entered settlement agreement with Galantos Pharma to extinguish all future royalty and milestone obligations under the Memogain APA.
- One-time payment of EUR 5,214,220, representing approximately 40% discount to estimated present value of remaining obligations.
- Galantos is in liquidation; payment fully releases Alpha and related parties from any claims under the original agreement.
- Previously paid EUR 785,780 in royalties; the settlement eliminates all future contingent payments for benzgalantamine (ALPHA-1062).
- Payment due by April 15, 2026; agreement includes mutual releases, non-disparagement, and confidentiality provisions.

## SEC filing metadata
- accession: 0001213900-26-043517
- form_type: 8-K
- ticker: ACOG
- cik: 0001655923
- company_name: Alpha Cognition Inc.
- filed_at: 2026-04-14T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1655923/000121390026043517/0001213900-26-043517-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1655923/000121390026043517/ea0285983-8k_alpha.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-043517
- JSON: https://secwatch.observer/filing/0001213900-26-043517.json
- Plain text: https://secwatch.observer/filing/0001213900-26-043517.txt

## Source-grounded claims
- claim_id: 00557c5f83733f13609b49cb86d79e61eca356f9
  claim: Alpha Cognition Inc. entered into Early Settlement Agreement with Galantos Pharma GmbH i.L. valued at EUR 5,214,220 (effective 2026-04-10).
  evidence_excerpt: On April 10, 2026, Alpha Cognition Inc. (the “ Company ”) entered into a settlement agreement and mutual release (the “ Early Settlement Agreement ”) with Galantos Pharma GmbH i.L. a company in liquidation and incorporated under the laws of the Federal Republic of Germany (“ Galantos ”), to extinguish certain future payment obligations arising under the Memogain Asset Purchase Agreement dated August 23, 2013 (the “ Original Agreement ”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1655923/000121390026043517/0001213900-26-043517-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.